ITCI Annual Non Current Assets
$60.50 M
+$43.67 M+259.60%
31 December 2023
Summary:
As of January 21, 2025, ITCI annual long term assets is $60.50 million, with the most recent change of +$43.67 million (+259.60%) on December 31, 2023. During the last 3 years, it has risen by +$34.09 million (+129.07%). ITCI annual non current assets is now at all-time high.ITCI Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Quarterly Non Current Assets
$52.71 M
-$3.54 M-6.29%
30 September 2024
Summary:
As of January 21, 2025, ITCI quarterly long term assets is $52.71 million, with the most recent change of -$3.54 million (-6.29%) on September 30, 2024. Over the past year, it has increased by +$37.48 million (+245.92%). ITCI quarterly non current assets is now -12.86% below its all-time high of $60.50 million, reached on December 31, 2023.ITCI Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +259.6% | +245.9% |
| 3 y3 years | +129.1% | +245.9% |
| 5 y5 years | +3322.1% | +245.9% |
ITCI Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +259.6% | -12.9% | +245.9% |
| 5 y | 5-year | at high | +259.6% | -12.9% | +245.9% |
| alltime | all time | at high | -12.9% |
Intra-Cellular Therapies Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $52.71 M(-6.3%) |
| June 2024 | - | $56.25 M(-0.5%) |
| Mar 2024 | - | $56.51 M(-6.6%) |
| Dec 2023 | $667.80 M(-9.5%) | $60.50 M(+297.0%) |
| Sept 2023 | - | $15.24 M(-1.9%) |
| June 2023 | - | $15.53 M(-3.3%) |
| Mar 2023 | - | $16.06 M(-4.5%) |
| Dec 2022 | $737.96 M(+57.9%) | $16.82 M(-24.4%) |
| Sept 2022 | - | $22.24 M(-2.0%) |
| June 2022 | - | $22.70 M(+12.2%) |
| Mar 2022 | - | $20.24 M(-10.6%) |
| Dec 2021 | $467.28 M(-32.4%) | $22.64 M(-4.6%) |
| Sept 2021 | - | $23.73 M(-2.7%) |
| June 2021 | - | $24.39 M(-3.9%) |
| Mar 2021 | - | $25.39 M(-3.9%) |
| Dec 2020 | $690.90 M(+200.0%) | $26.41 M(-0.1%) |
| Sept 2020 | - | $26.43 M(+18.2%) |
| June 2020 | - | $22.36 M(+10.3%) |
| Mar 2020 | - | $20.27 M(-2.8%) |
| Dec 2019 | $230.32 M(-35.2%) | $20.86 M(-1.0%) |
| Sept 2019 | - | $21.07 M(-2.1%) |
| June 2019 | - | $21.52 M(-1.5%) |
| Mar 2019 | - | $21.85 M(+1135.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $355.44 M(-24.2%) | $1.77 M(-24.2%) |
| Sept 2018 | - | $2.33 M(-3.3%) |
| June 2018 | - | $2.41 M(-2.9%) |
| Mar 2018 | - | $2.49 M(+9.4%) |
| Dec 2017 | $469.22 M(+20.9%) | $2.27 M(+200.7%) |
| Sept 2017 | - | $755.40 K(+7.2%) |
| June 2017 | - | $704.70 K(+3.4%) |
| Mar 2017 | - | $681.40 K(-3.1%) |
| Dec 2016 | $388.20 M(-19.7%) | $703.40 K(-6.6%) |
| Sept 2016 | - | $753.50 K(-5.1%) |
| June 2016 | - | $794.40 K(-1.1%) |
| Mar 2016 | - | $803.30 K(-5.2%) |
| Dec 2015 | $483.26 M(+268.9%) | $847.40 K(-1.2%) |
| Sept 2015 | - | $857.40 K(+8.1%) |
| June 2015 | - | $793.10 K(+25.7%) |
| Mar 2015 | - | $630.70 K(+402.5%) |
| Dec 2014 | $130.99 M(+242.5%) | $125.50 K(-2.3%) |
| Sept 2014 | - | $128.40 K(-4.7%) |
| June 2014 | - | $134.80 K(-49.2%) |
| Mar 2014 | - | $265.50 K(+32.9%) |
| Dec 2013 | $38.25 M(>+9900.0%) | $199.80 K(-3.2%) |
| Sept 2013 | - | $206.50 K(>+9900.0%) |
| June 2013 | - | $0.00 |
| Mar 2013 | $4100.00 | - |
FAQ
- What is Intra-Cellular Therapies annual long term assets?
- What is the all time high annual non current assets for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual non current assets year-on-year change?
- What is Intra-Cellular Therapies quarterly long term assets?
- What is the all time high quarterly non current assets for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly non current assets year-on-year change?
What is Intra-Cellular Therapies annual long term assets?
The current annual non current assets of ITCI is $60.50 M
What is the all time high annual non current assets for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual long term assets is $60.50 M
What is Intra-Cellular Therapies annual non current assets year-on-year change?
Over the past year, ITCI annual long term assets has changed by +$43.67 M (+259.60%)
What is Intra-Cellular Therapies quarterly long term assets?
The current quarterly non current assets of ITCI is $52.71 M
What is the all time high quarterly non current assets for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly long term assets is $60.50 M
What is Intra-Cellular Therapies quarterly non current assets year-on-year change?
Over the past year, ITCI quarterly long term assets has changed by +$37.48 M (+245.92%)